Attorneys Jason Klimek and James Mann recently discussed the challenges of cannabis rescheduling with the Hartford Business Journal.

Jason, co-leader of the firm’s Cannabis Industry Team, said rescheduling will require a positive recommendation from an administrative law judge to the U.S. Drug Enforcement Agency. He said if that does happen, it will likely spur immediate lawsuits.

“There’s procedures that have to be followed, and because this is controversial there will be a lot of people who will be looking at every single aspect of it,” he told the publication. “An executive order doesn’t override statute and regulation.”

James, special counsel for the firm’s Tax Practice Group, said he doesn’t expect rescheduling to happen in 2026, and potentially not even in 2027. He also told the publication it is not entirely clear whether the rescheduling would even apply to recreational cannabis, or just to cannabis that’s produced for medical patients.

Read the full Hartford Business Journal article for more details. (Subscription may be required.)